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Parkinson’s disease (PD), first described by James Parkinson in 1817, is a chronic, 
progressive neurodegenerative disorder. The pathologic hallmark is a deterioration of 
the substantia nigra of yet unknown causes, resulting in a deficiency of dopamine, an 
important neurotransmitter for the basal ganglia circuit and the presence of cytoplasmic 
eosinophilic inclusions named Lewy bodies, in which α-synuclein is the major 
constituent. Recent work implicates abnormal protein accumulation, protein 
phosphorylation, mitochondrial dysfunction and oxidative stress as common pathways 
implicated in PD pathogenesis. Polyphenolic compounds are commonly found in both 
edible and medicinal plants, and they have been reported to have multiple biological 
effects, including antioxidant activity. The budding yeast Saccharomyces cerevisiae has 
been used as a model to study several neurodegenerative diseases, including biological 
function of α-synuclein, as well as its toxicity. The heterologous expression of wild-type 
and A53T mutant form of α-synuclein causes toxicity in cells. Therefore, the aim of this 
study was to evaluate the possible protective effect of Hypericum perforatum phenolic 
compounds (quercetin, kaempferol and biapigenine), in the toxicity induced by the 
heterologous expression of α-synuclein, using the yeast Saccharomyces cerevisiae as a 
model. Preliminary results indicate that the presence of these phenolic compounds 
decrease the protein accumulation in cells expressing α-synuclein. We concluded that 
these phenolic compounds apparently have beneficial biological properties that 
consequently could have a potential use in preventing Parkinson’s disease. 
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